Published in BioSpectrum India on 1 September 2026, this feature by Vrushti Kothari examines how mergers and acquisitions are becoming an increasingly important growth strategy for India’s life sciences startups. From expanding product portfolios and acquiring complementary technologies to strengthening intellectual property and entering international markets, strategic acquisitions can help companies scale faster than developing every capability independently.
Contributing to the discussion, Dr. V. Premnath, Founder Director of Venture Center, highlights the motivations behind startup acquisitions, including expanding market opportunities, combining complementary technologies, improving the utilisation of sales and marketing investments, and gaining access to customers, brands and innovation capabilities. He also points to their significance as potential exit and value-creation opportunities for startups and investors. His perspective underscores how strategic consolidation can improve efficiency and productivity across India’s healthcare and life sciences ecosystem.